Home > Insider Trading > Filing (0001562180-24-006927)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1822462	Foghorn Therapeutics Inc.	FHTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1939167	Carlos Costa	500 Technology Square Ste #700 Cambridge MA 02139	Chief People Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-09-20	35,756	$3.72	35,756	No	4	M	Direct
Common Stock	Disposition	2024-09-20	35,756	$10.04	0	No	4	S	Direct
Common Stock	Acquisiton	2024-09-23	857	$3.72	857	No	4	M	Direct
Common Stock	Disposition	2024-09-23	857	$10.17	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2024-09-20	35,756	$0.00	35,756	$3.72
Common Stock	Stock Option (right to buy)	Disposition	2024-09-23	857	$0.00	857	$3.72

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
40,646		2029-02-12	No	4	M	Direct
39,789		2029-02-12	No	4	M	Direct

Footnotes

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.22 per share.
The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested.